NovaDel Pharma, Inc.

In just its third Rx drug advertisement enforcement action this year, the US FDA issued a warning letter objecting to promotional material for Zolpimist , the oral spry formulation of the sleep aid z

Research has shown that going without 7-8 hours of sleep each night takes a great toll on the human body, resulting in an increased risk for obesity, diabetes, cardiovascular disease, mental illness,

Pfizer delays Phase III study with GlycoMimetics drug; Pharmacyclics, Servier end agreement; TG Therapeutics licenses drug from Rhizen; Takeda invests $25m in BioMotiv; and Amherst buys NovaDel's Zolp

Just like it did last year with Sanofi's Ambien (zolpidem) and other zolpidem-containing products, the FDA on 15 May told Sunovion Pharmaceuticals to lower the recommended starting dose of its sleep a